Thurston Springer Miller Herd & Titak’s Orthofix Medical OFIX Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.48K	Buy	600 +300	+100%	+$3.31K	﹤0.01%	973
2026 Q1	$3.44K	Buy	+300	New	+$3.96K	﹤0.01%	1102
2025 Q3	–	Sell	-200	Closed	-$2.23K	–	1105
2025 Q2	$2.23K	Buy	+200	New	+$2.48K	﹤0.01%	1401

Other funds holding OFIX

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

KMC

Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's OFIX Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Orthofix Medical (OFIX) stake by 100% in Q2 2026, buying an estimated $3.31K and bringing the position to 600 shares worth $5.48K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Thurston Springer Miller Herd & Titak first reported a position in OFIX in Q2 2025 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

Thurston Springer Miller Herd & Titak held 600 shares of Orthofix Medical worth $5.48K as of Q2 2026.
Thurston Springer Miller Herd & Titak bought 300 Orthofix Medical shares in Q2 2026, an estimated $3.31K.
Orthofix Medical made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #973 holding.
Thurston Springer Miller Herd & Titak first reported a position in Orthofix Medical in Q2 2025 and has held it in 3 quarters since.
22 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.